- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/11 - Orthomyxoviridae, p. ex. virus de l'influenza
Détention brevets de la classe C07K 14/11
Brevets de cette classe: 619
Historique des publications depuis 10 ans
|
24
|
23
|
38
|
42
|
39
|
33
|
34
|
42
|
36
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Medicago Inc. | 138 |
20 |
| Sanofi Pasteur Inc. | 356 |
17 |
| Icahn School of Medicine at Mount Sinai | 935 |
16 |
| Janssen Vaccines & Prevention B.V. | 295 |
16 |
| Aramis Biotechnologies Inc. | 55 |
16 |
| FluGen, Inc. | 36 |
13 |
| Intervet International B.V. | 1272 |
11 |
| Intervet Inc. | 895 |
10 |
| Longhorn Vaccines and Diagnostics, LLC | 87 |
9 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
9 |
| Peptcell Limited | 27 |
8 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3126 |
7 |
| Duke University | 3058 |
6 |
| Academia Sinica | 935 |
6 |
| AVIR Green Hills Biotechnology Research Development Trade AG | 11 |
6 |
| The Regents of the University of California | 19812 |
4 |
| Massachusetts Institute of Technology | 10013 |
4 |
| University of Florida Research Foundation, Inc. | 3989 |
4 |
| Bionor Immuno AS | 20 |
4 |
| Cornell Research Foundation, Inc. | 275 |
4 |
| Autres propriétaires | 429 |